Results per Page:
Conducting RNA reconnaissance
Fred Hutch researchers invent a CRISPR screening method to understand RNA-binding proteins often mutated in cancer and other diseases
‘Manufacturing scientist’ believes in the machinery that powers Fred Hutch’s cell therapies
Dr. Folashade Otegbeye is the recipient of the Fleischauer Family Endowed Chair in Cell and Gene Therapy Translation
Patients’ own autoantibodies may hold key to boosting cancer immunotherapy response
A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments
Age-dependent genetic alterations in AML patients
From the Meshinchi Lab, Translational Science & Therapeutics Division
Premature immune aging occurs in children with leukemia
From Drs. Kavita Dhodapkar and Madhav Dhodapkar, Translational Science & Therapeutics Division
Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award
National award honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
A chair built together
Collective fundraising effort honors Kyle Thomas Spane, fuels research in colon cancer prevention
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
In the race to replicate, it’s better to think small-scale
From The Bedalov Lab, Human Biology and Translational Science and Therapeutics Divisions
Leonard and Norma Klorfine Endowed Chair for Clinical Research awarded to Dr. Geoffrey Hill
Funding will help facilitate inter-institutional collaboration and foundational data capture for immunological research
New tools in the pipeline for treating immune cell disorders
From the Walter Lab, Translational Sciences & Therapeutics Division
Cigarettes or vapes, pick your poison
From the Fong Lab, Translational Sciences & Therapeutics Division